Related Experiment Video
Updated: Jul 13, 2026

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
Published on: February 3, 2021
Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial
Robert F van Es1, Jan J C Jonker, Freek W A Verheugt
1Julius Centre for General Practice and Patient Oriented Research, University Medical Centre Utrecht, Netherlands.
Insights
Oral anticoagulants or combination therapy with aspirin and anticoagulants are more effective than aspirin alone for reducing cardiovascular events after myocardial infarction. Combination therapy increased minor bleeding risk.
Area of Science:
- Cardiology
- Pharmacology
- Clinical Trials
Background:
- Aspirin and oral anticoagulants are used to prevent recurrent ischemic events post-myocardial infarction.
- Optimal long-term antiplatelet and anticoagulant strategies require further investigation.
- Balancing efficacy and bleeding risk is crucial in managing acute coronary events.
Purpose of the Study:
- To compare the long-term effectiveness of aspirin, oral anticoagulants, and combination therapy after acute coronary events.
- To assess the safety profile, particularly bleeding risk, associated with each treatment strategy.
Main Methods:
- A randomized open-label trial involving 999 patients across 53 sites.
- Patients were assigned to low-dose aspirin, high-intensity oral anticoagulation, or combined low-dose aspirin and moderate-intensity oral anticoagulation.
- Follow-up extended to 26 months, with the primary endpoint being myocardial infarction, stroke, or death.
Main Results:
- Combination therapy (aspirin + anticoagulants) and oral anticoagulants alone showed greater efficacy in reducing the primary endpoint compared to aspirin alone (p=0.03 and p=0.0479, respectively).
- Major bleeding rates were similar across all groups.
- Minor bleeding occurred more frequently in the combination therapy group (15%) compared to aspirin (5%) or anticoagulants alone (8%).
Conclusions:
- High-intensity oral anticoagulants or combined aspirin and moderate-intensity oral anticoagulants are more effective than aspirin alone for reducing cardiovascular events and death post-acute coronary events.
- While effective, combination therapy is associated with an increased risk of minor bleeding.
- Treatment decisions should weigh the benefits of reduced ischemic events against the increased risk of bleeding.
Background:
Antiplatelet treatment with aspirin and oral anticoagulants reduces recurrence of ischaemic events after myocardial infarction. We aimed to investigate which of these drugs is more effective in the long term after acute coronary events, and whether the combination of aspirin and oral anticoagulants offers greater benefit than either of these agents alone, without excessive risk of bleeding.
Methods:
In a randomised open-label trial in 53 sites, we randomly assigned 999 patients to low-dose aspirin, high-intensity oral anticoagulation, or combined low-dose aspirin and moderate intensity oral anticoagulation. Patients were followed up for a maximum of 26 months. The primary composite endpoint was first occurrence of myocardial infarction, stroke, or death.
Findings:
The primary endpoint was reached in 31 (9%) of 336 patients on aspirin, in 17 (5%) of 325 on anticoagulants (hazard ratio 0.55 [95% CI 0.30-1.00], p=0.0479), and in 16 (5%) of 332 on combination therapy (0.50 [0.27-0.92], p=0.03). Major bleeding was recorded in three (1%) patients on aspirin, three (1%) on anticoagulants (1.03 [0.21-5.08], p=1.0), and seven (2%) on combination therapy (2.35 [0.61-9.10], p=0.2). Frequency of minor bleeding was 5%, 8% (1.68 [0.92-3.07], p=0.20), and 15% (3.13 [1.82-5.37], p=<0.0001), in the three groups, respectively. 164 patients permanently discontinued the study drug. Analyses were done by intention to treat.
Interpretation:
In patients recently admitted with acute coronary events, treatment with high-intensity oral anticoagulants or aspirin with medium-intensity oral anticoagulants was more effective than aspirin on its own in reduction of subsequent cardiovascular events and death.
Related Concept Videos
Mitral Stenosis II: Clinical features and Diagnostic Tests
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies